Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
Curr Microbiol ; 81(5): 118, 2024 Mar 16.
Article in English | MEDLINE | ID: mdl-38492019

ABSTRACT

Synthesizing nanoparticles through a green synthesis approach is common nowadays. Cyanobacteria have attained great importance in the field of biosynthesis of nanoparticles as there is no use of toxic chemicals as reducing or capping agents for the synthesis of metal oxide nanoparticles. Micronutrient-based nano-formulations have become a topic of great interest in recent times due to their various advantageous properties and applications in agriculture. The current study aims to exploit the potential cyanobacterial strains isolated from different locations such as freshwater and soil ecosystems. The potential cyanobacterial isolates were screened based on their multiple plant growth promoting (PGP) attributes such as Indol acetic acid (IAA) production, siderophores, and phosphate solubilization. After the screening of cyanobacteria based on multiple PGP activities, the cyanobacterial strain was identified at the species level as Pseudanabaena foetida RJ1, based on microscopy and molecular characterization using 16S rRNA gene sequencing. The cyanobacterial biomass extract and cell-free extracts are utilized for the synthesis of CuO micronutrient Nanoparticles (NPs). The cyanobacterial strain Pseudanabaena foetida RJ1 possesses plant growth-promoting (PGP) attributes that provide reduction and capping for CuO NPs. The synthesized NPs were characterized and subjected to make a nano-formulation, utilizing the cyanobacteria-mediated CuO NPs along with low-cost zeolite as an adsorbent. The application of cyanobacterial biomass extract and cell-free extract provided an excellent comparative aspect in terms of micronutrient NP synthesis. The NPs in the form of formulations were applied to germinated paddy seeds (Pusa Basmati -1509) with varying concentrations (5, 10, 15 mg/l). Effects of cyanobacteria based CuO NPs on hydroponically grown paddy crops were analyzed. The application of nano-formulations has shown a significant increase in plant growth promotion in rice plants under hydroponics conditions. There is no such type of comparative investigation reported earlier, and NPs of micronutrients can be utilized as a new economic nanofertilizer and can be applied to plants for their growth promotion.


Subject(s)
Cyanobacteria , Metal Nanoparticles , Nanoparticles , Oryza , Copper/pharmacology , Hydroponics , RNA, Ribosomal, 16S/genetics , Ecosystem , Metal Nanoparticles/chemistry , Micronutrients , Plant Extracts
2.
Malays J Med Sci ; 28(1): 51-58, 2021 Feb.
Article in English | MEDLINE | ID: mdl-33679220

ABSTRACT

BACKGROUND: Lipomas are benign adipocytic tumours. Surgical excision is the gold standard for treating such lipomas, but it results in unaesthetic scarring. METHODS: A total of 126 patients were randomised into two groups. The patients in Group A underwent mesotherapy (n = 66) and those in Group B underwent surgery (n = 60). The patients in Group A group received six sessions of mesotherapy treatment at 2-week intervals. Both groups were followed up for 12 weeks, during which they were assessed for complications arising from treatment, reduction of the size of the lipoma and cosmetic outcomes. RESULTS: The overall mean age of the patients was 32.93 (± 10.1) years old and the mean volume of the lipomas was 2.29 (± 3.8) mL. A 55.86% (P = 0.0032) mean reduction in the volume of lipomas was noted in the patients who received mesotherapy, while one patient showed a gain of 16% by volume. The patients in Group A (cosmetic score ≥ 4: 63%) were happier with the treatment than those in Group B (cosmetic score ≥ 4: 21%). CONCLUSION: Our findings indicate that mesotherapy modestly reduces the volume of lipomas with very few and minor complications and excellent cosmetic outcomes.

3.
J Surg Oncol ; 105(6): 617-21, 2012 May.
Article in English | MEDLINE | ID: mdl-22215508

ABSTRACT

Desmoplastic Small Round Cell Tumor (DSRCT) is a rare and an aggressive malignancy with poor outcome. This tumor can co-express epithelial, neural, and mesenchymal markers. The molecular hallmark of DSRCT is the EWS-WT1 fusion protein. Despite the diversities in treatment modality, the best results have been seen with radical surgery and adjuvant or neoadjuvant chemotherapy.


Subject(s)
Abdominal Neoplasms/therapy , Desmoplastic Small Round Cell Tumor/therapy , Abdominal Neoplasms/genetics , Abdominal Neoplasms/mortality , Abdominal Neoplasms/pathology , Antibodies, Monoclonal/therapeutic use , Chemotherapy, Adjuvant , Chemotherapy, Cancer, Regional Perfusion , Desmoplastic Small Round Cell Tumor/genetics , Desmoplastic Small Round Cell Tumor/mortality , Desmoplastic Small Round Cell Tumor/pathology , Humans , Hyperthermia, Induced , Immunohistochemistry , Neoplasm Recurrence, Local , Neoplasm Staging , Oncogene Proteins, Fusion/genetics , Radiotherapy, Adjuvant , Tomography, X-Ray Computed , Translocation, Genetic
SELECTION OF CITATIONS
SEARCH DETAIL